Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
Florian Ewald(Universität Hamburg), Manfred Jücker(Universität Hamburg)
Cited by 42
Related Papers
The Role of mTOR Signaling as a Therapeutic Target in Cancer
|International Journal of Molecular Sciences|2021|259
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
|Molecular Cancer|2012|121
Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
|PLoS ONE|2016|99
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
|International Journal of Cancer|2013|86
All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines
|International Journal of Molecular Sciences|2024|6